Keunjung focuses her practice on securities offerings, corporate governance, and credit facilities for mutual funds, closed-end funds, and exchange-traded funds as well as formation and structuring of hedge funds and private equity funds.
Prior to joining Mintz, Keunjung was an associate and summer associate of a Philadelphia-based international law firm, where she prepared documents for a variety of securities, governance, and credit matters in the firm’s Boston and New York offices.
While in law school, Keunjung served as a legal intern for the International Foundation for Art Research in New York. She was also a Harlan Fiske Stone Scholar and served as an articles editor of the Columbia Journal of Law & the Arts.
Education
- Columbia Law School (JD)
- Harvard Graduate School of Design (MA)
- Brown University (BA, magna cum laude)
Languages
- Korean
Recent Insights
Viewpoints
Directors Beware — Your Emails and Texts Could Be Subject to Inspection Under Delaware Law
June 6, 2019 |Advisory
News & Press
The deal will take public ProKidney, a leading clinical-stage cellular therapeutics company focused on chronic kidney disease, and is expected to provide up to $825 million in gross cash proceeds.
Viewpoints
Directors Beware — Your Emails and Texts Could Be Subject to Inspection Under Delaware Law
June 6, 2019 | Advisory | By Marc Mantell, Keunjung Cho
Read about holdings from the Delaware Supreme Court and Delaware Court of Chancery determining that directors’ emails and texts may be subject to inspection in Section 220 actions.
Read more
News & Press
The deal will take public ProKidney, a leading clinical-stage cellular therapeutics company focused on chronic kidney disease, and is expected to provide up to $825 million in gross cash proceeds.